Qu’attendent les médecins spécialistes de la chimiothérapie des cancers du poumon ?

Abstract : OBJECTIVE: In an attempt to understand physicians' expectations of chemotherapy, a group of lung cancer specialists was involved in an online survey investigating their opinions by a self-questionnaire. The questionnaire described five different chemotherapy prescription situations for lung cancer patients (stages IIIB or IV). METHOD: A total of 30 expert specialists were invited; 22 responded (73%). For each of the clinical situations, the expert was asked for his opinion on 3 items: cure, prolongation of survival and alleviation of symptoms. Each item was judged on a Likert scale with categories between -2 "not at all probable" and +2 "quite likely". RESULTS: For "cure", the percentage of -2 responses differed significantly according to the clinical situation (Fisher test: P<0.00001). The trend test showed a relationship between the percentage of -2 responses and the suspected order of the clinical situations (Cochran-Armitage trend test: P<0.0001). For symptom alleviation, the percentage of responses +2 and +1 differed significantly according to the clinical situation (Fisher test: P=0.00013, trend test: P<0.0001). CONCLUSION: What specialist physicians expect of chemotherapy in terms of curability and symptom relief differs according to the actual statistical prognosis of each situation as presented in the literature. The worst prognostic situation leads to the strongest expectation in terms of symptom relief and, conversely, the lowest for curability.
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-02315289
Contributeur : Anthony Herrada <>
Soumis le : lundi 14 octobre 2019 - 13:37:01
Dernière modification le : mardi 15 octobre 2019 - 01:24:38

Identifiants

Citation

J.-L. Pujol, B. Roch, A. Coffy, J.-P. Mérel, J.-P. Daures. Qu’attendent les médecins spécialistes de la chimiothérapie des cancers du poumon ?. Revue des Maladies Respiratoires, Elsevier Masson, 2018, 35 (9), pp.919-928. ⟨10.1016/j.rmr.2018.06.008⟩. ⟨hal-02315289⟩

Partager

Métriques

Consultations de la notice

16